UBS Investor Note on Pharma in Emerging Markets

In the article ‘Can emerging markets fuel growth and restore trust in Pharma?’ Joshua Berlin, journalist for the ‘PharmAsiaNews’ discusses the investor note by UBS ‘Global Pharma: doing well by doing good’, issued September 2010. The Access To Medicine Index is used as one of the key sources for the UBS report. To give more insight on how pharmaceutical companies perform on access to medicine, Berlin interviewed Wim Leereveld. ‘Moreover, because excelling in least developed markets is so complicated – requiring new business models and strategies – success in these markets points to the quality of a company’s management team, which is a key differentiator for investors’, Wim says. Read the full article and the full UBS Report here.